Abstract
Hydroxyapatite (HA) orbital implants are made from the porous skeleton of a coral species allowing fibrovascular ingrowth, which favors tissue integration. HA (coral or synthetic) became one of the most commonly used materials for implants in anophthalmic patients in the 1990s and at the beginning of this century [9]. Synthetic HA is made of the same material, with predetermined size pores, and has become widely used in the past few years in the western countries.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bigham WJ, Stanley P, Cahill JM, Curran RW, Perry AC (1999) Fibrovascular ingrowth in porous ocular implants : effect of the material composition, porosity, growth factors, and coating. Ophthal Plast Reconstr Surg 15:317–325
Carle E, Rosen CE (1998) The Muller muscle flap for repair of an exposed hydroxyapatite orbital implant. Ophthal Plast Reconstr Surg 14:204–207
Charles NS, Soparkar CN, Patrinely JR (1998) Tarsal patch flap for orbital exposure. Ophthal Plast Reconstr Surg 14:391–397
Custer PL, Kennedy RH, Woog JJ, Kaltreider SA, Meyer DR (2003) Orbital implants in enucleation surgery. A report by the American Academy of Ophthalmology. Ophthalmology 110:2054–2061
De Potter P, Shields CL, Shields JA, Flanders AE, Rao VM (1992) Role of magnetic resonance imaging in the evaluation of the hydroxyapatite implant. Ophthalmology 99:824–829
El-Shahed Fak Sherif MM, Ahmed AT (1995) Management of tissue breakdown and exposure associated with orbital hydroxyapatite implants. Ophthal Plast Reconstr Surg 11:91–94
Goldberg RA, Holds JB, Ebrahimpour J (1992) Exposed hydroxyapatite implants. Report of six cases. Ophthalmology 99:831–836
Holck DEE, Dutton JJ, Proia A, Khawly J, Mittra R, Dev S, Nauman I (1988) Rate of vascularisation of coralline hydroxyapatite spherical implants pretreated with saline gentamicin, rTGF-beta 2 and autogenous plasma. Ophthalmic Plast Reconstr Surg 14:73–80
Jordan DR (2001) Problems associated with porous orbital implants. Oper Techn Oculoplast Orbital Reconstr Surg 4:39–47
Jordan DR, Chan S, Mawn L, Gilberg S, Dean T, Brownstein S, Hill VE (1999) Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology 106:505–512
Jordan DR, Brownstein S, Gilberg S, Coupal D, Kim S, Mawn L (2002) Hydroxyapatite and calcium phosphate coatings on aluminium oxide orbital implants. Can J Ophthalmol 37:7–13
Kaltreider SA, Newman SA (1996) Prevention and management of complications associated with the hydroxyapatite implant. Ophthal Plast Reconstr Surg 12:18–31
Kim Y-D, Goldberg RA, Shorr N, Kenneth D, Steinsapir VD (1994) Management of exposed hydroxyapatite orbital implants. Ophthalmology 101:1709–1715
Liao SL, Kao SC, Tseng JH, Lin LL (2005)Surgical coverage of exposed hydroxyapatite implant with retroauricular myoperiosteal graft. Br J Ophthalmol 89:92–95
Martin P, Ghabrial R (1998) Repair of exposed hydroxyapatite orbital implant by a tarsoconjunctival pedicle flap. Ophthalmology 105:1694–1697
Mourgues T, Adenis JP (2001) Repair of hydroxyapatite orbital implant exposure with a conjunctival Muller muscle flap. Oper Techn Oculoplast Orbit Reconstr Surg 4:36–38
Naugle TC Jr, Lee AM, Haik BG, Callahan MA (1999) Wrapping hydroxyapatite orbital implants with posterior auricular muscle complex grafts. Am J Ophthalmol 128:495–501
Pelletier CR, Jordan DR, Gilberg SM (1998) Use of temporalis fascia for exposed hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 14:198–203
Remulla HD, Rubin PA, Shore JW, Sutula FC, Townsend DJ, Woog JJ, Jahrling KV (1995) Complications of porous spherical orbital implants. Ophthalmology 102:586–593
Rubin PAD, Nicaeus TE, Warner MA, Remulla HD (1997) Effect of sucralfate and basic fibroblast growth factor on fibrovascular ingrowth into hydroxyapatite and porous polyethylene alloplastic implants using a novel rabbit model. Ophthal Plast Reconstr Surg 13:8–17
Sagoo MS, Olver JM (2004) Autogenous temporalis fascia patch graft for porous polyethylene (Medpor) sphere orbital implant exposure. Br J Ophthalmol 88:942–946
Shields CL, Shields JA, De Potter P, Singh AD (1994) Problems with hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol 78:702–706
Sires BS, Holds JB, Kincaid MC, Reddi AH (1997) Osteogenin-enhanced bone-specific differentiation in hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 13:244–251
Zambonin G, Grano M, Greco G, Oreffo RO, Triffit JT (1999) Hydroxyapatite coated with insulin-like growth factor 1 (IGF1) stimulates human osteoblast activity in vitro. Acta Orthop Scand 70:217–220
Zambonin G, Camerino C, Greco G, Patella V, Moretti B, Grano M (2000) Hydroxyapatite coated with heaptocyte growth factor (HGF) stimulates human osteoblasts in vitro. J Bone Joint Surg Br 82:457–460
Editor information
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2007). Hydroxyapatite Orbital Implant Exposure: Symptoms, Physiopathology, Treatment. In: Guthoff, R., Katowitz, J. (eds) Oculoplastics and Orbit. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33677-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-540-33677-8_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33675-4
Online ISBN: 978-3-540-33677-8
eBook Packages: MedicineMedicine (R0)